{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T12:39:43Z","timestamp":1784637583467,"version":"3.55.0"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA013330"],"award-info":[{"award-number":["P30CA013330"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bcp.2026.118090","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T23:19:07Z","timestamp":1779319147000},"page":"118090","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"P1","title":["High-throughput screening for novel drug combinations using patient-derived organoids"],"prefix":"10.1016","volume":"251","author":[{"given":"Natalie","family":"Thielen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoyuan","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.bcp.2026.118090_b0005","doi-asserted-by":"crossref","first-page":"7634","DOI":"10.1073\/pnas.78.12.7634","article-title":"Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells","volume":"78","author":"Martin","year":"1981","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7244","key":"10.1016\/j.bcp.2026.118090_b0010","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nature07935","article-title":"Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche","volume":"459","author":"Sato","year":"2009","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bcp.2026.118090_b0015","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s43556-023-00165-9","article-title":"Patient-derived organoids in human cancer: a platform for fundamental research and precision medicine","volume":"5","author":"Qu","year":"2024","journal-title":"Mol Biomed"},{"issue":"5","key":"10.1016\/j.bcp.2026.118090_b0020","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1158\/2159-8290.CD-16-1154","article-title":"Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine","volume":"7","author":"Pauli","year":"2017","journal-title":"Cancer Discov."},{"issue":"7","key":"10.1016\/j.bcp.2026.118090_b0025","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41568-018-0007-6","article-title":"Organoids in cancer research","volume":"18","author":"Drost","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bcp.2026.118090_b0030","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/7651_2016_10","article-title":"Drug Sensitivity Assays of Human Cancer Organoid Cultures","volume":"1576","author":"Francies","year":"2019","journal-title":"Methods Mol. Biol."},{"issue":"10","key":"10.1016\/j.bcp.2026.118090_b0035","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1038\/s41591-019-0584-2","article-title":"A rectal cancer organoid platform to study individual responses to chemoradiation","volume":"25","author":"Ganesh","year":"2019","journal-title":"Nat. Med."},{"issue":"513","key":"10.1016\/j.bcp.2026.118090_b0040","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay2574","article-title":"Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients","volume":"11","author":"Ooft","year":"2019","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.bcp.2026.118090_b0045","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41698-021-00168-1","article-title":"Patient-derived organoids as a predictive biomarker for treatment response in cancer patients","volume":"5","author":"Wensink","year":"2021","journal-title":"npj Precis. Oncol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118090_b0050","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s12943-025-02466-9","article-title":"Exploring personalized prediction of clinical chemotherapy efficacy and revealing tumor heterogeneity using patient-derived 3D bioprinting gastric cancer models","volume":"24","author":"Du","year":"2025","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2026.118090_b0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0279821","article-title":"A living biobank of matched pairs of patient-derived xenografts and organoids for cancer pharmacology","volume":"18","author":"Xu","year":"2023","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.bcp.2026.118090_b0060","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/s12276-021-00641-8","article-title":"Organoids in image-based phenotypic chemical screens","volume":"53","author":"Lukonin","year":"2021","journal-title":"Exp. Mol. Med."},{"issue":"4","key":"10.1016\/j.bcp.2026.118090_b0065","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nmeth1015","article-title":"Three-dimensional culture models of normal and malignant breast epithelial cells","volume":"4","author":"Lee","year":"2007","journal-title":"Nat. Methods"},{"issue":"2","key":"10.1016\/j.bcp.2026.118090_b0070","article-title":"A large-scale organoid-based screening platform to advance drug repurposing in pancreatic cancer","volume":"2","author":"Mainardi","year":"2022","journal-title":"Cell Genom"},{"issue":"4","key":"10.1016\/j.bcp.2026.118090_b0075","first-page":"513","article-title":"Challenges and opportunities toward enabling phenotypic screening of complex and 3D cell models, Future","volume":"7","author":"Horman","year":"2015","journal-title":"Med. Chem."},{"issue":"8","key":"10.1016\/j.bcp.2026.118090_b0080","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1093\/jmcb\/mjaa036","article-title":"Development of a miniaturized 3D organoid culture platform for ultra-high-throughput screening","volume":"12","author":"Du","year":"2020","journal-title":"J. Mol. Cell Biol."},{"issue":"7","key":"10.1016\/j.bcp.2026.118090_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.slasd.2024.100182","article-title":"Development of an automated 3D high content cell screening platform for organoid phenotyping","volume":"29","author":"Bozal","year":"2024","journal-title":"SLAS Discov"},{"issue":"9","key":"10.1016\/j.bcp.2026.118090_b0090","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/s41551-020-0565-2","article-title":"High-throughput automated organoid culture via stem-cell aggregation in microcavity arrays","volume":"4","author":"Brandenberg","year":"2020","journal-title":"Nat. Biomed. Eng."},{"issue":"1","key":"10.1016\/j.bcp.2026.118090_b0095","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40364-022-00356-6","article-title":"Clinical translation of patient-derived tumour organoids- bottlenecks and strategies","volume":"10","author":"Foo","year":"2022","journal-title":"Biomark Res"},{"issue":"7899","key":"10.1016\/j.bcp.2026.118090_b0100","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41586-022-04437-2","article-title":"Effective drug combinations in breast, colon and pancreatic cancer cells","volume":"603","author":"Jaaks","year":"2022","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bcp.2026.118090_b0105","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s43856-025-00991-8","article-title":"Drug combination-wide association studies of cancer","volume":"5","author":"Lalagkas","year":"2025","journal-title":"Commun Med (lond)"},{"issue":"6378","key":"10.1016\/j.bcp.2026.118090_b0110","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1126\/science.aao2774","article-title":"Patient-derived organoids model treatment response of metastatic gastrointestinal cancers","volume":"359","author":"Vlachogiannis","year":"2018","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.bcp.2026.118090_b0115","doi-asserted-by":"crossref","first-page":"955","DOI":"10.15252\/msb.20177697","article-title":"Screening drug effects in patient-derived cancer cells links organoid responses to genome alterations","volume":"13","author":"Jabs","year":"2017","journal-title":"Mol. Syst. Biol."},{"issue":"43","key":"10.1016\/j.bcp.2026.118090_b0120","doi-asserted-by":"crossref","first-page":"13308","DOI":"10.1073\/pnas.1516689112","article-title":"Preserved genetic diversity in organoids cultured from biopsies of human colorectal cancer metastases","volume":"112","author":"Weeber","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.bcp.2026.118090_b0125","first-page":"281","article-title":"Organoids as a Model for Colorectal Cancer","volume":"12","author":"Young","year":"2016","journal-title":"Curr. Colorectal Cancer Rep."},{"issue":"1","key":"10.1016\/j.bcp.2026.118090_b0130","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.1038\/s41467-020-19058-4","article-title":"Automated microfluidic platform for dynamic and combinatorial drug screening of tumor organoids","volume":"11","author":"Schuster","year":"2020","journal-title":"Nat. Commun."},{"issue":"31","key":"10.1016\/j.bcp.2026.118090_b0135","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adt1851","article-title":"Machine learning-assisted exploration of multidrug-drug administration regimens for organoid arrays","volume":"11","author":"Yakavets","year":"2025","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.bcp.2026.118090_b0140","doi-asserted-by":"crossref","DOI":"10.1093\/stmcls\/sxae070","article-title":"High-throughput solutions in tumor organoids: from culture to drug screening","volume":"43","author":"Zuo","year":"2025","journal-title":"Stem Cells"},{"key":"10.1016\/j.bcp.2026.118090_b0145","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1016\/S0959-8049(22)01105-4","article-title":"High content screening of ovarian organoid models to accelerate anti-cancer drug discovery","volume":"174","author":"Hornsveld","year":"2022","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"10.1016\/j.bcp.2026.118090_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2020.100056","article-title":"Patient-Derived Tumor Organoid Rings for Histologic Characterization and High-Throughput Screening","volume":"1","author":"Nguyen","year":"2020","journal-title":"STAR Protoc."},{"issue":"7","key":"10.1016\/j.bcp.2026.118090_b0155","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1158\/2159-8290.CD-18-1522","article-title":"Oral Mucosal Organoids as a potential Platform for Personalized Cancer Therapy","volume":"9","author":"Driehuis","year":"2019","journal-title":"Cancer Discov."},{"issue":"2","key":"10.1016\/j.bcp.2026.118090_b0160","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s13402-022-00750-0","article-title":"OrBITS: label-free and time-lapse monitoring of patient derived organoids for advanced drug screening","volume":"46","author":"Deben","year":"2023","journal-title":"Cell. Oncol. (Dordr.)"},{"issue":"9","key":"10.1016\/j.bcp.2026.118090_b0165","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1177\/24725552211020668","article-title":"High-Throughput Imaging Assay for Drug Screening of 3D Prostate Cancer Organoids","volume":"26","author":"Choo","year":"2021","journal-title":"SLAS Discov"},{"issue":"9","key":"10.1016\/j.bcp.2026.118090_b0170","article-title":"An Automated Organoid Platform with Inter-organoid Homogeneity and Inter-patient Heterogeneity","volume":"1","author":"Jiang","year":"2020","journal-title":"Cell Rep. Med."},{"issue":"2","key":"10.1016\/j.bcp.2026.118090_b0175","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/2472630319877376","article-title":"Rapid Production and Recovery of Cell Spheroids by Automated Droplet Microfluidics","volume":"25","author":"Langer","year":"2020","journal-title":"SLAS Technol."},{"key":"10.1016\/j.bcp.2026.118090_b0180","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2023.41.16_suppl.e15574","article-title":"Refractory colorectal cancer patient derived MicroOrganoSpheres (MOS) to enable correlation of targeted therapy combination response with clinical outcomes","author":"Ding","year":"2023","journal-title":"Proc. Am. Soc. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.bcp.2026.118090_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109429","article-title":"A pan-cancer organoid platform for precision medicine","volume":"36","author":"Larsen","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.bcp.2026.118090_b0190","doi-asserted-by":"crossref","unstructured":"L. Li, D. LaBarbera, 3D high-content screening of organoids for drug discovery, (2017).","DOI":"10.1016\/B978-0-12-409547-2.12329-7"},{"issue":"10","key":"10.1016\/j.bcp.2026.118090_b0195","doi-asserted-by":"crossref","first-page":"803","DOI":"10.4252\/wjsc.v11.i10.803","article-title":"Microfluidic three-dimensional cell culture of stem cells for high-throughput analysis","volume":"11","author":"Kim","year":"2019","journal-title":"World J Stem Cells"},{"issue":"12","key":"10.1016\/j.bcp.2026.118090_b0200","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1021\/acsptsci.4c00565","article-title":"A High-Throughput and Logarithm-Serial-Dilution Microfluidic Chip for Combinational Drug Screening on Tumor Organoids","volume":"7","author":"Yan","year":"2024","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"12","key":"10.1016\/j.bcp.2026.118090_b0205","article-title":"A high-throughput 3D culture microfluidic platform for multi-parameter phenotypic and omics profiling of patient-derived organoids","volume":"2024","author":"Botrugno","year":"2024","journal-title":"bioRxiv"},{"issue":"1","key":"10.1016\/j.bcp.2026.118090_b0210","doi-asserted-by":"crossref","first-page":"14672","DOI":"10.1038\/s41598-018-33055-0","article-title":"Drug screening of biopsy-derived spheroids using a self-generated microfluidic concentration gradient","volume":"8","author":"Mulholland","year":"2018","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.bcp.2026.118090_b0215","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23123355","article-title":"A Microfluidic Spheroid Culture Device with a Concentration Gradient Generator for High-Throughput Screening of Drug Efficacy","volume":"23","author":"Lim","year":"2018","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.bcp.2026.118090_b0220","doi-asserted-by":"crossref","first-page":"34107","DOI":"10.1063\/1.4739460","article-title":"On-chip three-dimensional tumor spheroid formation and pump-less perfusion culture using gravity-driven cell aggregation and balanced droplet dispensing","volume":"6","author":"Kim","year":"2012","journal-title":"Biomicrofluidics"},{"issue":"1","key":"10.1016\/j.bcp.2026.118090_b0225","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13104-021-05445-7","article-title":"Drug synergy scoring using minimal dose response matrices","volume":"14","author":"Makela","year":"2021","journal-title":"BMC. Res. Notes"},{"issue":"26","key":"10.1016\/j.bcp.2026.118090_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/S0024-3205(97)01030-8","article-title":"Efficient designs for studying synergistic drug combinations","volume":"61","author":"Tallarida","year":"1997","journal-title":"Life Sci."},{"key":"10.1016\/j.bcp.2026.118090_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2025.102665","article-title":"Combinatorial screening of nanomedicines in patient-derived cancer organoids facilitates efficient cancer therapy","volume":"61","author":"Liang","year":"2025","journal-title":"Nano Today"},{"key":"10.1016\/j.bcp.2026.118090_b0240","article-title":"Targeting cancer stem cells predicts response and reverses chemoresistance in ascites-derived ovarian cancer organoids","author":"Zhang","year":"2026","journal-title":"BMC Med."},{"key":"10.1016\/j.bcp.2026.118090_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.slasd.2025.100222","article-title":"Combinatorial screen of targeted agents with the PI3K inhibitors inavolisib, alpelisib, duvelisib, and copanlisib in multi-cell type tumor spheroids","volume":"32","author":"Dexheimer","year":"2025","journal-title":"SLAS Discov"},{"issue":"2","key":"10.1016\/j.bcp.2026.118090_b0250","article-title":"Drug screening and genome editing in human pancreatic cancer organoids identifies drug-gene interactions and candidates for off-label treatment","volume":"2","author":"Hirt","year":"2022","journal-title":"Cell Genom"},{"key":"10.1016\/j.bcp.2026.118090_b0255","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.18489","article-title":"Targeting mutant RAS in patient-derived colorectal cancer organoids by combinatorial drug screening","volume":"5","author":"Verissimo","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.bcp.2026.118090_b0260","series-title":"Good research practice in non-clinical pharmacology and biomedicine","author":"Bespalov","year":"2020"},{"issue":"4","key":"10.1016\/j.bcp.2026.118090_b0265","first-page":"291","article-title":"Replicates and repeats\u2013what is the difference and is it significant?","volume":"13","author":"Vaux","year":"2012","journal-title":"A Brief Discussion of Statistics and Experimental Design, EMBO Rep"},{"issue":"7","key":"10.1016\/j.bcp.2026.118090_b0270","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/s41583-020-0313-3","article-title":"Reproducibility of animal research in light of biological variation","volume":"21","author":"Voelkl","year":"2020","journal-title":"Nat. Rev. Neurosci."},{"issue":"8","key":"10.1016\/j.bcp.2026.118090_b0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109568","article-title":"Organoid-based drug screening reveals neddylation as therapeutic target for malignant rhabdoid tumors","volume":"36","author":"Calandrini","year":"2021","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.bcp.2026.118090_b0280","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.bcp.2026.118090_b0285","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1177\/1947601912440575","article-title":"Quantitative methods for assessing drug synergism","volume":"2","author":"Tallarida","year":"2011","journal-title":"Genes Cancer"},{"issue":"3","key":"10.1016\/j.bcp.2026.118090_b0290","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1744-7348.1939.tb06990.x","article-title":"The toxicity of poisons applied jointly 1","volume":"26","author":"Bliss","year":"1939","journal-title":"Ann. Appl. Biol."},{"issue":"6","key":"10.1016\/j.bcp.2026.118090_b0295","first-page":"285","article-title":"The problem of synergism and antagonism of combined drugs","volume":"3","author":"Loewe","year":"1953","journal-title":"Arzneimittelforschung"},{"issue":"2","key":"10.1016\/j.bcp.2026.118090_b0300","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0031-6997(25)06847-4","article-title":"The search for synergy: a critical review from a response surface perspective","volume":"47","author":"Greco","year":"1995","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bcp.2026.118090_b0305","first-page":"504","article-title":"Searching for Drug Synergy in complex Dose-Response Landscapes using an Interaction Potency Model, Comput Struct","volume":"13","author":"Yadav","year":"2015","journal-title":"Biotechnol. J."},{"issue":"1","key":"10.1016\/j.bcp.2026.118090_b0310","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13046-025-03385-9","article-title":"Advanced organoid models for targeting Kras-driven lung adenocarcinoma in drug discovery and combination therapy","volume":"44","author":"Tas","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2026.118090_b0315","volume":"3D","author":"Simonneau","year":"2025","journal-title":"Cell Viability Protocol Using Cell Titer-Glo"},{"issue":"1","key":"10.1016\/j.bcp.2026.118090_b0320","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s13287-022-02902-3","article-title":"Assay establishment and validation of a high-throughput organoid-based drug screening platform","volume":"13","author":"Li","year":"2022","journal-title":"Stem Cell Res Ther"},{"issue":"7","key":"10.1016\/j.bcp.2026.118090_b0325","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1089\/ten.tec.2021.0060","article-title":"Cell Viability Assays in Three-Dimensional Hydrogels: a Comparative Study of Accuracy","volume":"27","author":"Dominijanni","year":"2021","journal-title":"Tissue Eng. Part C Methods"},{"key":"10.1016\/j.bcp.2026.118090_b0330","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/978-1-61779-080-5_21","article-title":"Cell sensitivity assays: the ATP-based tumor chemosensitivity assay","volume":"731","author":"Glaysher","year":"2011","journal-title":"Methods Mol. Biol."},{"issue":"5","key":"10.1016\/j.bcp.2026.118090_b0335","first-page":"1039","article-title":"ATP assay: ability to distinguish cytostatic from cytocidal anticancer drug effects","volume":"77","author":"Garewal","year":"1986","journal-title":"J. Natl Cancer Inst."},{"key":"10.1016\/j.bcp.2026.118090_b0340","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.semcdb.2019.05.016","article-title":"Reconciling environment-mediated metabolic heterogeneity with the oncogene-driven cancer paradigm in precision oncology","volume":"98","author":"Vander Linden","year":"2020","journal-title":"Semin. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118090_b0345","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3390\/organoids1010008","article-title":"Metabolic studies in organoids: current applications, opportunities and challenges","volume":"1","author":"Richiardone","year":"2022","journal-title":"Organoids"},{"key":"10.1016\/j.bcp.2026.118090_b0350","doi-asserted-by":"crossref","DOI":"10.3791\/66072","article-title":"Multiplexed Live-Cell Imaging for Drug responses in Patient-Derived Organoid Models of Cancer","author":"Colling","year":"2024","journal-title":"J vis Exp (203)"},{"key":"10.1016\/j.bcp.2026.118090_b0355","doi-asserted-by":"crossref","unstructured":"S. Ding, C. Hsu, Z. Wang, N.R. Natesh, R. Millen, M. Negrete, N. Giroux, G.O. Rivera, A. Dohlman, S. Bose, T. Rotstein, K. Spiller, A. Yeung, Z. Sun, C. Jiang, R. Xi, B. Wilkin, P.M. Randon, I. Williamson, D.A. Nelson, D. Delubac, S. Oh, G. Rupprecht, J. Isaacs, J. Jia, C. Chen, J.P. Shen, S. Kopetz, S. McCall, A. Smith, N. Gjorevski, A.C. Walz, S. Antonia, E. Marrer-Berger, H. Clevers, D. Hsu, X. Shen, Patient-derived micro-organospheres enable clinical precision oncology, Cell Stem Cell 29(6) (2022) 905-917 e6.","DOI":"10.1016\/j.stem.2022.04.006"},{"issue":"1","key":"10.1016\/j.bcp.2026.118090_b0360","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s42003-024-05966-4","article-title":"OrgaSegment: deep-learning based organoid segmentation to quantify CFTR dependent fluid secretion","volume":"7","author":"Lefferts","year":"2024","journal-title":"Commun. Biol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118090_b0365","doi-asserted-by":"crossref","first-page":"19841","DOI":"10.1038\/s41598-023-46485-2","article-title":"Development of a deep learning based image processing tool for enhanced organoid analysis","volume":"13","author":"Park","year":"2023","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.bcp.2026.118090_b0370","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1010584","article-title":"OrganoID: a versatile deep learning platform for tracking and analysis of single-organoid dynamics","volume":"18","author":"Matthews","year":"2022","journal-title":"PLoS Comput. Biol."},{"issue":"3","key":"10.1016\/j.bcp.2026.118090_b0375","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.slasd.2022.03.004","article-title":"deepOrganoid: a brightfield cell viability model for screening matrix-embedded organoids","volume":"27","author":"Powell","year":"2022","journal-title":"SLAS Discov"},{"issue":"1","key":"10.1016\/j.bcp.2026.118090_b0380","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-024-07329-5","article-title":"Development and validation of the Normalized Organoid Growth Rate (NOGR) metric in brightfield imaging-based assays","volume":"7","author":"Deben","year":"2024","journal-title":"Commun. Biol."},{"issue":"30","key":"10.1016\/j.bcp.2026.118090_b0385","doi-asserted-by":"crossref","first-page":"38832","DOI":"10.1021\/acsami.4c07665","article-title":"AI-Powered Microfluidics: Shaping the Future of Phenotypic Drug Discovery","volume":"16","author":"Liu","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"7","key":"10.1016\/j.bcp.2026.118090_b0390","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9070705","article-title":"Multiplex Patient-based Drug Response Assay in Pancreatic Ductal Adenocarcinoma","volume":"9","author":"Armstrong","year":"2021","journal-title":"Biomedicines"},{"issue":"8","key":"10.1016\/j.bcp.2026.118090_b0395","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/nbt.2989","article-title":"Microfluidic organs-on-chips","volume":"32","author":"Bhatia","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bcp.2026.118090_b0400","doi-asserted-by":"crossref","DOI":"10.51335\/organoid.2022.2.e4","article-title":"Recent advances and challenges in organoid-on-a-chip technology","volume":"2","author":"Suhito","year":"2022","journal-title":"Organoid"},{"issue":"1","key":"10.1016\/j.bcp.2026.118090_b0405","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13045-025-01688-0","article-title":"Cancer associated fibroblasts in cancer development and therapy","volume":"18","author":"Jia","year":"2025","journal-title":"J. Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.bcp.2026.118090_b0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2025.114656","article-title":"Constructing a co-culture model of cancer-associated fibroblasts and ovarian cancer organoids and studying mechanisms of drug resistance","volume":"450","author":"Ma","year":"2025","journal-title":"Exp. Cell Res."},{"issue":"5","key":"10.1016\/j.bcp.2026.118090_b0415","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006290","article-title":"Emerging organoid-immune co-culture models for cancer research: from oncoimmunology to personalized immunotherapies","volume":"11","author":"Magre","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bcp.2026.118090_b0420","doi-asserted-by":"crossref","unstructured":"E.M. Holloway, J.H. Wu, M. Czerwinski, C.W. Sweet, A. Wu, Y.H. Tsai, S. Huang, A.E. Stoddard, M.M. Capeling, I. Glass, J.R. Spence, Differentiation of Human Intestinal Organoids with Endogenous Vascular Endothelial Cells, Dev Cell 54(4) (2020) 516-528 e7.","DOI":"10.1016\/j.devcel.2020.07.023"},{"key":"10.1016\/j.bcp.2026.118090_b0425","doi-asserted-by":"crossref","unstructured":"C.J. Childs, H.M. Poling, K. Chen, Y.H. Tsai, A. Wu, A. Vallie, M.K. Eiken, S. Huang, C.W. Sweet, R. Schreiner, Z. Xiao, R.C. Spencer, S.A. Paris, A.S. Conchola, J.W. Villanueva, M.F. Anderman, E.M. Holloway, A. Singh, R.J. Giger, M.M. Mahe, C. Loebel, M.A. Helmrath, K.D. Walton, S. Rafii, J.R. Spence, Coordinated differentiation of human intestinal organoids with functional enteric neurons and vasculature, Cell Stem Cell 32(4) (2025) 640-651 e9.","DOI":"10.1016\/j.stem.2025.02.007"},{"key":"10.1016\/j.bcp.2026.118090_b0430","doi-asserted-by":"crossref","unstructured":"Y. Miao, N.M. Pek, C. Tan, C. Jiang, Z. Yu, K. Iwasawa, M. Shi, D.O. Kechele, N. Sundaram, V. Pastrana-Gomez, D.I. Sinner, X. Liu, K.C. Lin, C.L. Na, K. Kishimoto, M.C. Yang, S. Maharjan, J. Tchieu, J.A. Whitsett, Y.S. Zhang, K.W. McCracken, R.J. Rottier, D.N. Kotton, M.A. Helmrath, J.M. Wells, T. Takebe, A.M. Zorn, Y.W. Chen, M. Guo, M. Gu, Co-development of mesoderm and endoderm enables organotypic vascularization in lung and gut organoids, Cell 188(16) (2025) 4295-4313 e27.","DOI":"10.1016\/j.cell.2025.05.041"},{"issue":"2","key":"10.1016\/j.bcp.2026.118090_b0435","article-title":"Personalized Models of Biological Barriers and their Diseases: recent Progress with Organs-On-Chips","volume":"10","author":"Buck","year":"2026","journal-title":"Adv Biol (weinh)"},{"key":"10.1016\/j.bcp.2026.118090_b0440","article-title":"A Microwell Array embedded Microfluidic Gradient Platform for Drug Screening on Tumor Spheroids","author":"Liu","year":"2026","journal-title":"Small"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226004259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226004259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T05:29:06Z","timestamp":1783920546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226004259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":88,"alternative-id":["S0006295226004259"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118090","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-throughput screening for novel drug combinations using patient-derived organoids","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118090","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118090"}}